Bank of America’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bank of America’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-78,700	Closed	-$7.63M	–	7655
2019 Q3	$7.63M	Hold	78,700	–	–	﹤0.01%	2795
2019 Q2	$8.06M	Buy	78,700 +77,600	+7,055%	+$8.37M	﹤0.01%	2779
2019 Q1	$125K	Buy	+1,100	New	+$80.8K	﹤0.01%	5756
2018 Q3	–	Sell	-3,600	Closed	-$298K	–	7593
2018 Q2	$298K	Sell	3,600 -46,400	-93%	-$3.58M	﹤0.01%	5196
2018 Q1	$3.33M	Buy	50,000 +45,000	+900%	+$2.6M	﹤0.01%	3451
2017 Q4	$257K	Sell	5,000 -5,000	-50%	-$359K	﹤0.01%	5295
2017 Q3	$892K	Buy	+10,000	New	+$759K	﹤0.01%	4590
2017 Q2	–	Sell	-22,500	Closed	-$1.2M	–	7303
2017 Q1	$1.2M	Buy	+22,500	New	+$1.34M	﹤0.01%	4307

Bank of America's ONCE Position: Q4 2019 in Review

Bank of America sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 100,827 shares — an estimated $9.78M sold.

Bank of America first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $17.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Bank of America reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Bank of America sold 100,827 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $9.78M.
Bank of America first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
Bank of America's Spark Therapeutics, Inc. Common Stock position peaked at $17.9M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.